MO

More Impact AG

Develops, acquires, and commercializes patented medical tech like needle-free injection systems.

Overview

Corporate Details

ISIN(s):
DE000A1PG979
LEI:
529900Q0OR2CA082QN74
Country:
Switzerland
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

More Impact AG is a publicly listed high-tech medical hub focused on developing, acquiring, and commercializing patented medical innovations. The company's business model integrates four key pillars: in-house development of proprietary technologies, strategic M&A to expand its intellectual property portfolio, commercialization through exclusive distribution and licensing agreements, and value optimization via the selective sale of patents or business divisions. Its portfolio, with patents valued at over €1 billion, features innovations such as the Speedinject needle-free injection system and the Z-Boxx and M-Boxx inhalers. Formerly known as AEE Gold AG, the company has pivoted its strategy to invest in and advance the future of medicine and healthcare.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all More Impact AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for More Impact AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
TISSUE REGENIX GROUP PLC Logo
Develops regenerative biological products for orthopaedic and dental markets.
United Kingdom TRX
T&R Biofab Co., Ltd Logo
Develops 3D bioprinted scaffolds for tissue repair in orthopedics, surgery, and dentistry.
South Korea 246710
Developing disruptive, pre-approval technologies for the spinal stabilization market.
United Kingdom N/A
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy UBM
UXN Co., Ltd. Logo
Develops advanced continuous glucose monitoring systems and sensors for diabetes management.
South Korea 337840
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany VMED
Vitrolife Logo
A global provider of medical devices and genetic testing services for IVF clinics to improve outcomes.
Sweden VITR
Vitruvia Medical AG Logo
Circular economy provider for robotic surgery instruments for European clinics and hospitals.
Germany 991
Wonbiogen Co.,Ltd. Logo
Develops and manufactures advanced wound care solutions and medical materials.
South Korea 307280
Xvivo Perfusion Logo
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
Sweden XVIVO

Talk to a Data Expert

Have a question? We'll get back to you promptly.